CN104306734B - 治疗糖尿病坏疽外用膏药制剂及其制备方法 - Google Patents
治疗糖尿病坏疽外用膏药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104306734B CN104306734B CN201410547760.4A CN201410547760A CN104306734B CN 104306734 B CN104306734 B CN 104306734B CN 201410547760 A CN201410547760 A CN 201410547760A CN 104306734 B CN104306734 B CN 104306734B
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- medicine
- blood
- diabetic gangrene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 206010012665 Diabetic gangrene Diseases 0.000 title claims abstract description 23
- 239000002674 ointment Substances 0.000 title claims description 6
- 210000004369 blood Anatomy 0.000 claims abstract description 54
- 239000008280 blood Substances 0.000 claims abstract description 54
- 239000003814 drug Substances 0.000 claims abstract description 43
- 239000011505 plaster Substances 0.000 claims abstract description 22
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 241001523681 Dendrobium Species 0.000 claims abstract description 15
- 241000555712 Forsythia Species 0.000 claims abstract description 14
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 13
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 13
- 244000248557 Ophiopogon japonicus Species 0.000 claims abstract description 13
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 12
- 235000005865 Symphytum officinale Nutrition 0.000 claims abstract description 12
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 11
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 11
- 240000002299 Symphytum officinale Species 0.000 claims abstract description 11
- 240000002045 Guettarda speciosa Species 0.000 claims abstract description 8
- 241000405414 Rehmannia Species 0.000 claims abstract description 8
- 241000013557 Plantaginaceae Species 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 235000017276 Salvia Nutrition 0.000 claims description 5
- 239000008159 sesame oil Substances 0.000 claims description 5
- 235000011803 sesame oil Nutrition 0.000 claims description 5
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical group C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 240000007164 Salvia officinalis Species 0.000 claims description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 24
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 238000001784 detoxification Methods 0.000 abstract description 6
- 238000005469 granulation Methods 0.000 abstract description 6
- 230000003179 granulation Effects 0.000 abstract description 6
- 244000132619 red sage Species 0.000 abstract description 6
- 238000011160 research Methods 0.000 abstract description 5
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 2
- 230000009756 muscle regeneration Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 206010012601 diabetes mellitus Diseases 0.000 description 18
- 210000002683 foot Anatomy 0.000 description 18
- 206010052428 Wound Diseases 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 210000001124 body fluid Anatomy 0.000 description 14
- 239000010839 body fluid Substances 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 12
- 208000015220 Febrile disease Diseases 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 206010017711 Gangrene Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 208000008960 Diabetic foot Diseases 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 244000061520 Angelica archangelica Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 208000034656 Contusions Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010049927 Dry gangrene Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000405911 Rehmannia glutinosa Species 0.000 description 3
- 241001072909 Salvia Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 238000002266 amputation Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000001338 necrotic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 239000008627 Shengji ointment Substances 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 240000000966 Allium tricoccum Species 0.000 description 1
- 235000006905 Allium tricoccum Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000003790 Foot Ulcer Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037569 Purulent discharge Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040030 Sensory loss Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000008950 Sommerlauch Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241001442052 Symphytum Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种疗效更好的治疗糖尿病坏疽外用膏药制剂及其制备方法。本发明药物由生西洋参、石斛、麦冬、玄参、生地、紫草、地丁、公英、金银花、连翘、当归、丹参、桃仁、红花、血竭进行组合制成的,将这些药物组合使得各药物功效产生协同作用,从而有效地共奏益气养阴、清热解毒、活血化瘀、祛腐生肌之效。本发明兼纳中西医理论研究所得,该制剂具有补气养阴,清热解毒,化瘀通络,解毒生肌之功效,用于临床,实验证明,效果明显。
Description
技术领域
本发明属于中医中药技术领域,具体涉及一种治疗糖尿病坏疽外用膏药制剂及其制备方法。
背景技术
糖尿病坏疽是糖尿病合并足部疼痛、溃疡及肢端缺血坏疽等病变,统称为糖尿病足。糖尿病足可导致足趾坏疽脱落,创面合并感染甚至筋肉腐烂,久不收口或合并败血症而死亡。我国糖尿病患者并发肢端坏疽的约占0.9~1.7%,老年糖尿病人并发肢端坏疽约占2.8~14.5%,并且有逐年升高的趋势。治疗糖尿病足首先是严格控制血糖,使血糖正常或接近正常水平,在抗感染和改善微循环的基础上,积极采用局部外科清创。干性坏疽者,截去完全坏死的足趾后,外敷传统的祛腐生肌的中药生肌膏。而中药成方生肌膏是对在病人没有糖尿病的情况下研制的祛腐生肌的膏药,不具备养阴润燥、益气生津之功效。
祖国医学对糖尿病坏疽的认识:糖尿病性肢端坏疽是一种慢性进行性波及肢体大、中、微血管的特殊病变,以肢体末端疼痛、感染、溃疡、坏疽为主要临床症状。因多发于下肢、足趾、足底部,所以称为“糖尿病足”。本病属于糖尿病常见严重慢性并发症,也是糖尿病病人致残主要原因之一。在糖尿病人足坏疽的发生率比非糖尿病人高17倍,在欧美国家糖尿病足坏疽的发生率占住院糖尿病人数的20%。国内糖尿病人并发足坏疽的约占0.9%-1.7%,而60岁以上老年糖尿病明显低于西方国家,但我国糖尿病并发足坏疽的发病率明显高于一般疾病病人,而且一旦坏疽发生感染则病情加重。对于本病,国外传统的治疗方法采取高位截肢手术。1988年lerni报道美国传统糖尿病患者每年有4万人被截肢。过去国内糖尿病合并肢端坏疽的截肢率占21%-66.6%,给糖尿病人造成终生残疾和极大痛苦。近年来,由于防治技术的发展,采用中西医结合方法,以中药配合西药内科保守治疗为主,结合外科动脉重建术等方法,疗效明显提高,截肢率明显下降。
发明内容
根据临床实践,参阅近年来国内外对糖尿病的研究,认为气阴两虚,血脉不适,邪毒内陷为本病的重要病理基础。提出本病应在控制血糖的基础上,以补气养阴,清热解毒,化瘀通络,解毒生肌组方研制成本发明外敷膏药。为此,本发明人经过长期临床实践、反复研究,终于找到了一种副作用小、标本兼治,能够更为有效治疗糖尿病坏疽外用膏药制剂;本发明目的是提供一种疗效更好的治疗糖尿病坏疽外用膏药制剂及其制备方法。
本发明药物组成成份的用量是发明人经过长期大量摸索总结得来的,各组份用量在下述重量份都具有较好的疗效:西洋参10~30份、石斛10~20份、麦冬10~20份、玄参10~25份、生地5~20份、紫草10~25份、地丁5~10份、公英5~15份、金银花5~20份、连翘5~10份、当归15~30份、丹参30~40份、桃仁5~10份、红花10~20份、血竭5~10份。
为得到上述外用膏药制剂,其制备方法如下:取置容器,将上述重量份的中药西洋参、石斛、麦冬、玄参、生地、紫草、地丁、公英、金银花、连翘、当归、丹参、桃仁、红花洗净晾干、混合,放入容器内,再往容器内倒入麻油2000ml,上述麻油的量以浸没上述药物为准,侵泡七天后武火加热麻油至油沸腾,文火加热至药为金黄色为止,弃火停止加热,捞出药渣弃去,上述等分量的血竭研极细末加入油内,混合搅匀,油放至常温加极细面轻粉及石蜡至成软膏状,即可制成治疗糖尿病坏疽外用膏药制剂。
本发明药物选择生西洋参、石斛、麦冬、玄参、生地、紫草、地丁、公英、金银花、连翘、当归、丹参、桃仁、红花、血竭进行组合,将这些药物组合使得各药物功效产生协同作用,从而有效地共奏益气养阴、清热解毒、活血化瘀、祛腐生肌之效。本方剂各组分药物的功用分别是:
西洋参:性苦,微甘,寒。归心、肺、肾经。其功效:补气养阴,清火生津。西洋参有良好的养阴生津之功,用于津液亏虚而致的口干舌燥,单用煎服即有效;如与沙参、石斛等养阴生津药配用,其效更佳。西洋参长于补气养阴。用于热病气阴两伤所致的烦渴少气,单用水煎服即有良效;若与鲜生地,鲜石斛等养阴清热生津药配伍,疗效更佳。
石斛:性甘,微寒。归胃、肾经。其功效:养胃生津,滋阴除热。石斛既能滋肾阴,又可清虚热,用于阴虚津亏所致的低热日久不退,可与生地黄、白薇等养阴药、清虚热药同用;石斛具明目和强腰膝之功,用于肝肾阴亏的视物昏花、眩晕目暗,与枸杞、菊花等配用,如石斛夜光丸;治肾阴亏损,腰膝软弱,与熟地黄、龟板同用;石斛既能养胃生津,又可除热,鲜石斛生津清热之力更佳。用于热病津伤所致的烦渴、咽干舌燥,与沙参、天花粉同用。如用于胃阴不足,津亏口渴、咽干舌燥、大便秘结,与生地黄、知母等同用。
麦冬:又称麦门冬、寸冬,别名野韭菜。其味甘、微苦,入心、肺、胃经,质柔多汁,养阴生津,润肺清心。用于肺燥干咳,虚痨咳嗽,津伤口渴,心烦失眠,内热消渴,肠燥便秘,咽白喉。养阴生津,润肺止咳,用于肺胃阴虚之津少口渴、干咳咯血;心阴不足之心悸易惊及热病后期热伤津液等证。“麦门甘寒,解渴祛烦,补心清肺,虚热自安。”正如《本草纲目》所说“久服轻身,不老不饥”。冬季天气干燥,懂得养生的人,常会用麦冬泡水饮。
玄参:性味苦、甘、咸、寒,入肺、胃、肾经。具凉血滋阴,解毒软坚之功。此药苦寒清热,甘咸滋肾,为滋阴降火之要药。《本草纲目》言其“滋阴降火,解斑毒,利咽喉,通小便、血滞”。《药品化义》言其“凡治肾虚,大有分别,肾之经虚则寒而湿,宜温补之;肾之脏虚则热而燥,宜凉补之;独此凉润滋肾,功胜知柏,特为肾脏君药”。本品清热解毒,凉血滋阴,对温热病热入营血,肾阴亏虚,虚火上炎所致的各种咽喉病症都有很好的治疗作用。
生地黄:味甘、苦,性寒。归心、肝、肺经。功能主治具有清热凉血功效,用于温热病热入营血,壮热神昏,口干舌绛,如清营汤;治温病后期,余热未尽,阴液已伤,夜热早凉,舌红脉数者,如青蒿鳖甲汤;可用于治温热病热入营血,血热毒盛,吐血衄血,斑疹紫黑,如四生丸;养阴生津功效,用于津伤口渴,内热消渴,治温病伤阴,肠燥便秘,如增液汤。
紫草:性味甘,寒。归心、肝经。其功效:清热凉血,活血,解毒,透疹。用于热毒斑疹,热毒疮疡。有降血糖、抗炎、抗病原微生物、解热、镇痛作用等。
地丁:性寒,味苦。《纲目》:苦辛,寒,无毒。入心、肝经。清热利湿,解毒消肿。治疔疮,痈肿,瘰疬,黄疸,痢疾,腹泻,目赤,喉痹,毒蛇咬伤。
公英:性甘寒清解,苦以开泄。功专解毒消肿,为治乳痈要药。清热解毒:可用于热毒证,尤善清肝热,治疗肝热目赤肿痛以及多种感染、化脓性疾病;消痈散结:治疗热毒壅结于肌肉所致的痈肿疮毒,高热不退。对乳痈有良效,能解毒散结通乳,可内服或外敷,常配金银花等同用。另外还可配大黄、丹皮治疗肠痈。蒲公英又称尿床草,对于利尿有非常好的效果,它具有丰富的维生素A和C及矿物质,对消化不良、便秘都有改善的作用。叶子还有改善湿疹、舒缓皮肤炎、关节不适的净血功效。
金银花:性甘、寒,气芳香。甘寒清热而不伤胃,芳香透达又可祛邪。金银花既能宣散风热,还善清解血毒,用于各种热性病,如身热、发疹、发斑、热毒疮痈、咽喉肿痛等证,均效果显著。
连翘:性苦,微寒。归肺、心、胆经。连翘有广谱抗菌作用,对金黄色葡萄球菌、贺氏痢疾杆菌有很强的抑制作用,对其他致病菌、流感病毒、真菌都有一定抑制作用。连翘有抗炎作用。本品所含齐墩果酸有强心、利尿及降血压作用,维生素P可降低血管通透性及脆性,防止溶血。煎剂有镇吐、抗肝损伤作用,清热解毒,消肿散结,疏散风热。主治痈肿疮毒,痰核瘰疬,外感风热,温病初起,热淋涩痛等。
当归:性甘、辛、微苦,性温。归肝、心、脾经。香郁行散,可升可降;具有补血,活血,调经止痛,润肠通便的功效。主治血虚、血瘀诸症:月经不调,经闭,痛经,润燥滑肠,肠燥便难;气血两虚,肝郁气滞,头痛眩晕,心悸肢麻,风湿痹痛,跌打损伤,痈疽疮疡,既能保胎,又是产后之良药。现代已把当归用于治疗冠心病、血栓闭塞性脉管炎、急性缺血性脑中风、肌肉关节疼痛、神经痛、心绞痛等,亦取得了一定的疗效。
丹参:性苦,微寒。归心、心包、肝经。功效主治:活血祛瘀,凉血消痈,清心除烦。用于月经不调、血滞经闭、产后瘀滞腹痛、心腹疼痛、癥瘕积聚,以及肢体疼痛等证。疮痈肿痛,温热病热入营血,证见高热、时有谵语、烦躁不寐,或斑疹隐隐、舌红绛等,以及心悸怔忡、失眠等。
桃仁:性味苦、甘,平。归心、肝、大肠经。功效主治:活血祛瘀,润肠通便。用于痛经、血滞经闭、产后瘀滞腹痛、癥瘕、跌打损伤、瘀阻疼痛,肺痈、肠痈以及肠燥便秘。
红花:性味辛,温。归心、肝经。功效主治:活血通经,祛瘀止痛。用于妇人腹中气血刺痛以及跌打损伤瘀痛,以及关节疼痛等证。还可用于因热郁血滞所致斑疹色暗者。
血竭性平,味咸、甘,入心经、肝经。活血生肌,散瘀定痛。其主治跌打损伤,疮口不收,积血肿痛。
本发明治疗糖尿病坏疽外用膏药制剂是由发明人积十数年之教研和临床经验,兼纳中西医理论研究所得,该制剂具有补气养阴,清热解毒,化瘀通络,解毒生肌之功效,用于临床,实验证明,效果明显。
具体实施方式
本发明治疗糖尿病坏疽外用膏药制剂中的各组分的重量份配比在下述范围内都具有较好的疗效:西洋参10~30份、石斛10~20份、麦冬10~20份、玄参10~25份、生地5~20份、紫草10~25份、地丁5~10份、公英5~15份、金银花5~20份、连翘5~10份、当归15~30份、丹参30~40份、桃仁5~10份、红花10~20份、血竭5~10份。
实施例1:本发明是由下列重量份的原药制成的:西洋参10份、石斛10份、麦冬10份、玄参10份、生地5份、紫草10份、地丁5份、公英5份、金银花5份、连翘5份、当归15份、丹参30份、桃仁5份、红花10份、血竭5份。
实施例2:本发明是由下列重量份的原药制成的:西洋参30份、石斛20份、麦冬20份、玄参25份、生地20份、紫草25份、地丁10份、公英15份、金银花20份、连翘10份、当归30份、丹参40份、桃仁10份、红花20份、血竭10份。
实施例3:本发明是由下列重量份的原药制成的:西洋参20份、石斛15份、麦冬15份、玄参20份、生地15份、紫草20份、地丁8份、公英10份、金银花15份、连翘8份、当归25份、丹参35份、桃仁8份、红花15份、血竭8份。
为得到上述外用膏药制剂,其制备方法如下:取置容器,将上述重量份的中药西洋参、石斛、麦冬、玄参、生地、紫草、地丁、公英、金银花、连翘、当归、丹参、桃仁、红花洗净晾干、混合,放入容器内,再往容器内倒入麻油2000ml,上述麻油的量以浸没上述药物为准,侵泡七天后武火加热麻油至油沸腾,文火加热至药为金黄色为止,弃火停止加热,捞出药渣弃去,上述等分量的血竭研极细末加入油内,混合搅匀,油放至常温加极细面轻粉及石蜡至成软膏状,即可制成治疗糖尿病坏疽外用膏药制剂。
使用方法:先将糖尿病坏疽外用膏药制成纱布软膏,使用前创面无菌清创, 纱布软膏覆盖创面,外敷纱布覆盖,胶布固定,每日换药一次。内服降糖药,使血糖保持正常水平,如遇感染可配合抗菌素治疗。
临床观察资料
(一)本发明药物主要功能与治疗范围
1、主要功能:
清热、解毒、活血、化瘀、祛腐、生肌。
2、治疗范围:清热解毒、活血化瘀、祛腐生肌。用于疮疡肿痛,乳痈发背,溃烂流脓,浸淫黄水。尤其对糖尿病坏疽。
本发明药物的临床观察资料
1、一般资料临床资料:
同期收治的40例糖尿病坏疽患者,男18例,女22例;平均年龄50岁。糖尿病病程3~20年,糖尿病足病程1~18个月。
2、诊断标准及分级:
依病情轻重分为5级:0级:肢端供血不足,皮肤凉,呈紫褐色,伴有麻木、刺疼、烧灼感,感觉迟钝或丧失;1级:皮肤有开放性病灶,但未累及深部组织;Ⅱ级:感染病灶已侵犯深部肌肉组织,脓性分泌物。无肌腱韧带破坏;Ⅲ级:肌腱韧带受损,蜂窝组织炎融合形成大脓腔,无明显骨破坏;Ⅳ级:严重感染导致骨破坏,部分可出现干性或湿性坏疽。
0级0例,1级30例,Ⅱ级4例,Ⅲ级3例,Ⅳ级3例。
4、治疗方法:
将40例患者随机分为治疗组22例和对照组18例。两组均口服降糖药或注射胰岛索控制空腹血糖<7.0mm/L,同时予常规活血化瘀治疗。在此基础上治疗组局部消毒后外敷本发明糖尿病坏疽外用膏药,外用无菌纱布覆盖,每天换药1次,必要时用纱布引流(烘至45℃);对照组生肌玉红膏,外用无菌纱布覆盖,每天换药1次。两组出现严重感染时均根据细菌培养及药敏实验静脉应用抗生素。治疗2个月后观察两组疗效及不照反应。疗效判断标准:足部皮肤感觉正常,足背动脉搏动有力,溃疡创面完全愈合,临床分级0级为治愈;足部皮肤感觉部分恢复,足背动脉搏动较明显,溃疡创面缩小,分泌物减少,临床分级好转1个级别以上为有效;足部皮肤感觉无好转,足背动脉搏动弱或消失,溃疡创面无缩小,分泌物无减少,临床分级无好转或恶化为无效。
5、结果
治疗组治愈10例、有效11例、无效1例,总有效率95.5%;对照组治愈1例、有效6例、无效11例,总有效率38.9%。治疗组显效率(P<0.05)和总有效率(P<0.01)均显著高于对照组。治疗组1例局部出现瘙痒等皮肤过敏症状,应用抗过敏药物及延长换药间隔后消失。
病例一:患者林某某,男性,59岁。因外伤致右足破溃,就诊于其他医院伤情不见好转,转入我科。经门诊清疮包扎收入院。主要症状:表现为右足外侧破溃,创缘红肿,脓性清晰分泌物,可闻及臭秽气味,消渴,夜尿多,烦躁,失眠。检查:右足外侧糖尿病坏疽破溃创口3~4cm,创口深陷约2cm,创面红肿,分泌物为脓性清晰,臭秽气味,足背动脉搏动减弱,舌质红,苔少,脉涩。既往史:糖尿病六年,吸烟饮酒20年,空腹血糖11.2mmol/L,白细胞9.79×109/L。中医治以益气养阴,清热解毒,活血祛瘀之法。清疮创面外敷本发明糖尿病坏疽外用膏药,以蚕蚀方法逐日清创,剪除腐烂之组织,用新吉尔灭冲洗数遍后,敷本发明糖尿病坏疽外用膏药。每日一次换药。配合静脉滴注抗生素,活血化淤通络,控制血糖。二十天痊愈。
病例二:任某某,男性,74岁,农民。患者于10天前不明原因的右足中指发黑坏死,就诊于其他医院不见好转,转入我科经门诊清疮收住院。主要症状:右足暗紫,右足中指发黑坏死有臭秽气味,足背疼痛,夜间尤甚,口渴,喜饮,纳差,心慌,失眠。检查:右足皆发紫,中指发黑坏死,臭秽气味,皮肤发凉,足背动脉搏动减弱,舌质暗红、苔薄黄,脉弦细。空腹血糖14. 5mmol/L,既往史,糖尿病史四年,吸烟饮酒40年,心电图提示冠心病,心功能不全。中医治疗以活血化淤,温阳止痛之法,西医强心利尿,控制感染,控制血糖。外以蚕蚀方法逐日清创,剪除腐烂之组织,用双氧水、络合碘清洗创面,生理盐水冲洗数遍后,敷本发明糖尿病坏疽外用膏药。每日一次换。25天痊愈。
Claims (2)
1.一种治疗糖尿病坏疽外用膏药制剂,其特征在于所述治疗糖尿病坏疽外用膏药制剂是由下列重量份的原药制成的:
西洋参10~30份、石斛10~20份、麦冬10~20份、玄参10~25份、生地5~20份、紫草10~25份、地丁5~10份、公英5~15份、金银花5~20份、连翘5~10份、当归15~30份、丹参30~40份、桃仁5~10份、红花10~20份、血竭5~10份。
2.一种如权利要求1所述治疗糖尿病坏疽外用膏药制剂的制备方法,其特征在于该外用膏药制剂的制备方法如下:取置容器,将上述重量份的中药西洋参、石斛、麦冬、玄参、生地、紫草、地丁、公英、金银花、连翘、当归、丹参、桃仁、红花洗净晾干、混合,放入容器内,再往容器内倒入麻油,麻油的量以浸没上述药物为准,浸泡七天后武火加热麻油至油沸腾,文火加热至药为金黄色为止,弃火停止加热,捞出药渣弃去,所述分量的血竭研极细末加入油内,混合搅匀,油放至常温加极细面轻粉及石蜡至成软膏状,即可制成治疗糖尿病坏疽外用膏药制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410547760.4A CN104306734B (zh) | 2014-10-16 | 2014-10-16 | 治疗糖尿病坏疽外用膏药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410547760.4A CN104306734B (zh) | 2014-10-16 | 2014-10-16 | 治疗糖尿病坏疽外用膏药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104306734A CN104306734A (zh) | 2015-01-28 |
CN104306734B true CN104306734B (zh) | 2017-11-28 |
Family
ID=52362143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410547760.4A Expired - Fee Related CN104306734B (zh) | 2014-10-16 | 2014-10-16 | 治疗糖尿病坏疽外用膏药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104306734B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107638451A (zh) * | 2017-11-10 | 2018-01-30 | 郑州密丽药业有限公司 | 一种治疗脉管炎的中药制剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101780192A (zh) * | 2009-11-05 | 2010-07-21 | 李培梅 | 一种用于治疗因糖尿病足坏疽的外用中药 |
CN102319327A (zh) * | 2011-10-11 | 2012-01-18 | 张俊瑕 | 内外兼治治疗糖尿病足的中药 |
-
2014
- 2014-10-16 CN CN201410547760.4A patent/CN104306734B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101780192A (zh) * | 2009-11-05 | 2010-07-21 | 李培梅 | 一种用于治疗因糖尿病足坏疽的外用中药 |
CN102319327A (zh) * | 2011-10-11 | 2012-01-18 | 张俊瑕 | 内外兼治治疗糖尿病足的中药 |
Non-Patent Citations (2)
Title |
---|
刘再朋教授治疗糖尿病肢端坏疽经验简介;高国宇;《江苏中医药》;20050831;第26卷(第8期);第6-7页第1-2节 * |
辨证分型内外兼治配合西药治疗糖尿病足38例;王殿荣;《陕西中医》;20080430;第29卷(第4期);第426页左栏第3段 * |
Also Published As
Publication number | Publication date |
---|---|
CN104306734A (zh) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102861287B (zh) | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 | |
CN102178877A (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
CN101703651A (zh) | 一种治疗糖尿病坏疽的药物 | |
CN106581439A (zh) | 一种治疗创伤、糖尿病足和皮肤溃烂的中药组合物及其制备方法 | |
CN101601782B (zh) | 一种治疗脚癣的复方酊剂 | |
CN102872335B (zh) | 一种治疗糖尿病足的外用中药制剂及其制备方法 | |
CN116370576A (zh) | 一种伤口修复中药生肌膏及其制备方法 | |
CN104306734B (zh) | 治疗糖尿病坏疽外用膏药制剂及其制备方法 | |
CN104547251B (zh) | 一种治疗急性肠炎的脐贴及制备方法 | |
CN105327244A (zh) | 一种含有艾叶的治疗褥疮的中药组合物及其制备方法 | |
CN105031596A (zh) | 一种治疗钱币状湿疹的软膏及其制备方法 | |
CN105770347A (zh) | 一种纯中药配方的烧烫创疡油及其制备方法 | |
CN105250685A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
CN115154550B (zh) | 一种治疗溃疡型淋巴结结核的外用中药组合物 | |
CN110664936A (zh) | 一种褥疮膏 | |
CN104306707A (zh) | 一种治疗褥疮的药物组合物 | |
CN112972559B (zh) | 用于治疗骨和软组织化脓性炎症的中药组合物和中药合剂 | |
CN110403995B (zh) | 治疗浅静脉炎作用的中药组合物及制备、使用方法和应用 | |
CN107198763A (zh) | 一种防治小腿静脉曲张的外用中药及其制备方法 | |
CN106266207A (zh) | 一种治疗周围血管疾病的中药制剂及其制备方法 | |
CN106692491B (zh) | 一种祛除烫烧伤疤痕的药膏 | |
WO2025065255A1 (zh) | 一种烧烫伤药酊及其制备方法 | |
CN105832909A (zh) | 一种治疗皮肤坏死性溃疡的中药制剂 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN104257967A (zh) | 一种治疗运动损伤的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171128 Termination date: 20181016 |